William Marshall

BiOptix Diagnostics, Inc. develops biosensor for detection of bacteria and viruses. Its product 404pi offers scientists that require label-free, real-time detection of bio-molecular interactions an extremely high sensitivity, low noise instrument. The company was founded by Misha Plam, Slava Petropavlovskikh and Oyvind Nilsen in 2003 and is headquartered in Boulder, CO.

Colorado BioScience Association operates as an association for life sciences. The non-profit company is based in Denver, CO. The company was founded by Steve A. Orndorff. Jennifer Jones Paton has been the CEO of the company since 2016.

FluoroFinder LLC designs and develops flow cytometry products for research facilities. It offers flow cytometry, microscopy, and concierge services. The company was founded by Roland Marcus in 2014 and is headquartered in Boulder, CO.

Ribometrix, Inc. develops small molecule drugs that target functional RNA structures to create new avenues to treat human disease. The company was founded by Kevin Weeks and Katie Warner and is headquartered in Greenville, NC.

Part of GSK Plc, Elsie Biotechnologies Inc. is a private biopharmaceutical company dedicated to unlocking the full potential of oligonucleotide therapeutics. The company is based in San Diego, CA. Elsie Biotechnologies integrates discovery, development, and delivery to increase potency, decrease toxicity, and optimize delivery of oligonucleotide therapeutics. The company's platform accesses the entire oligonucleotide chemistry space to optimize gene silencing and splice switching, and develops novel oligonucleotide therapeutics that are more potent, safer, and easier to deliver to target tissues. Elsie Biotechnologies is focused on unlocking the full potential of RNA therapeutics to treat undruggable diseases. The company was founded in 2021 by Phil Baran and Philip E. Dawson. The CEO is Kevin Green. Elsie Biotechnologies was acquired by GSK Plc on June 06, 2024 for $50 million.

Dharmacon, Inc. engages in the research and development for ribonucleic acid synthesis. Its products are gene editing, RNA interference, cDNAs and ORFs, transfection, and viral packaging. The company was founded by Stephen Scaringe in 1995 and is headquartered in Lafayette, CO.